Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Angioedema Treatment Market?

There has been a fast-paced expansion in the angioedema treatment market size lately. The market is projected to rise from $2.72 billion in 2024 to $3.13 billion in 2025, with an annual compound growth rate (CAGR) of 15.0%. Factors contributing to this growth during the historic period include an increase in governmental support, higher diagnosis rates, a surge in autoimmune disorders, expansion in clinical trial activity, and the development of healthcare infrastructure.

What Growth Rate Is Forecasted for the Angioedema Treatment Market by 2029?

The market for angioedema treatment is projected to experience a swift expansion in the coming years. It is predicted to reach a value of $5.4 billion by 2029, with a 14.6% compound annual growth rate (CAGR). The expected growth during the forecast period is due to a rise in healthcare spending, increased consciousness about allergies, a growing incidence of chronic illnesses, a heightened occurrence and prevalence of angioedema, and an intensified focus on individualized medicine. Key trends to expect during this period include progress in diagnostic technologies, the merging of machine learning, investment in research and development, the implementation of telemedicine, and the ease of regulatory approvals leading to faster market penetration.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24460&type=smp

Which Key Companies Are Shaping the Future of the Angioedema Treatment Market?

Major companies operating in the angioedema treatment market are Sanofi SA, Takeda Pharmaceutical Company Limited, Viatris Inc., Otsuka Pharmaceutical Co. Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd, Cipla Inc., Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc., Salix Pharmaceuticals Ltd, BioCryst Pharmaceuticals Inc., Pharming Group NV, Pharvaris Netherlands B.V, Astria Therapeutics, Intellia Therapeutics, KalVista Pharmaceuticals Ltd., ADARx Pharmaceuticals, Adverum Biotechnologies Inc.

Which Factors Are Driving Demand in the Angioedema Treatment Industry?

The expected increase in rare disease cases is predicted to fuel the angioedema treatment market’s expansion. Rare diseases are medical conditions that only impact a minute part of the population and usually come with limited cure options and significant health influence. With the evolution of genetic testing and diagnostic technologies, the recognition and accurate diagnosis of these rare diseases, which were previously unobserved, are now possible. This trend has led to an increased reported prevalence. Treating angioedema is beneficial for rare diseases like hereditary angioedema as it provides specialized therapies to prevent and manage serious swelling incidents, thereby enhancing patient outcomes. For example, as reported by the US-based federal agency, Food and Drug Administration, over 7,000 rare diseases affected more than 30 million individuals in the United States as of November 2024. Thus, the angioedema treatment market is being propelled by the escalating incidence of these rare diseases.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24460&type=smp

How Is the Angioedema Treatment Market Segmented by Several Divisions?

The angioedema treatment market covered in this report is segmented –

1) By Type: Allergic Angioedema, Drug-Induced Angioedema, Idiopathic Angioedema, Hereditary Angioedema

2) By Route Of Administration: Injection, Oral

3) By End Use: Hospitals, Clinics, Research Organizations

1) By Allergic Angioedema: Antihistamines, Corticosteroids, Epinephrine, Immunotherapy, Allergen Avoidance Therapies

2) By Drug-Induced Angioedema: Discontinuation of Causative Drug, Antihistamines, Corticosteroids, Epinephrine, Bradykinin Pathway Inhibitors

3) By Idiopathic Angioedema: Empirical Antihistamine Therapy, Corticosteroid Therapy, Leukotriene Receptor Antagonists, Monoclonal Antibodies, Observation and Symptom Management

4) By Hereditary Angioedema: C1 Esterase Inhibitor Replacement Therapy, Bradykinin B2 Receptor Antagonists, Kallikrein Inhibitors, Attenuated Androgens, Antifibrinolytics

What are the Emerging Market Trends Driving the Growth of the Angioedema Treatment Industry?

Key players in the angioedema treatment market are concentrating their efforts on creating innovative remedies like subcutaneous injections to provide quicker and more comfortable relief for individuals suffering from severe hereditary angioedema (HAE) episodes. Subcutaneous injections, which deliver medication into the fatty tissue just under the skin, allow for consistent and gradual dissemination into the bloodstream. For example, in April 2025, CSL Limited, a biotechnology firm based in Australia, launched ANDEMBRY (garadacimab), a novel, fully human monoclonal antibody therapy used to prevent severe episodes in patients with hereditary angioedema (HAE). ANDEMBRY is the first pre-filled pen for monthly subcutaneous use, providing a convenient option for long-term prevention. The medicine achieves its effects by hindering activated Factor XII (Factor XIIa), a critical starter in the cascade resulting in angioedema, symbolizing a remarkable progress in HAE management by offering effective, patient-oriented disease control.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/angioedema-treatment-global-market-report

Which Regions Are Driving Growth in the Angioedema Treatment Market?

North America was the largest region in the angioedema treatment market in 2024. The regions covered in the angioedema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24460

This Report Delivers Insight On:

1. How big is the angioedema treatment market, and how is it changing globally?

2. Who are the major companies in the angioedema treatment market, and how are they performing?

3. What are the key opportunities and risks in the angioedema treatment market right now?

4. Which products or customer segments are growing the most in the angioedema treatment market?

5. What factors are helping or slowing down the growth of the angioedema treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model